Swapnil Rajpathak from Merck: Why Do Some Patients See a Delay in Intensification of Diabetes Care

Video

As patients with diabetes progress throughout their lives there may be a need to increase treatment to help manage their symptoms. A recent study looked at how likely patients are to intensify their treatment and what that can mean for their care.

%jwplayer%

As patients with diabetes progress throughout their lives there may be a need to increase treatment to help manage their symptoms. A recent study looked at how likely patients are to intensify their treatment and what that can mean for their care.

Speaking at the American Diabetes Association's annual meeting in New Orleans Swapnil Rajpathak, MD, from Merck discussed the results of this study and how it can affect this increasingly growing patient population. While this study looked at patients taking Metformin Rajpathak said it can be important for doctors to understand this research for patients with other treatment options as well.

Related Videos
Addressing HS Risks at the Genetic Level, with Kai Li, BSc
Maternal Hidradenitits Suppurativa Linked to Neonatal Mortality, Pediatric Hospitalization Risk
Laxmi Mehta, MD | Credit: American Heart Association
Reviewing 2023 with FDA Commissioner Robert M. Califf, MD
A Year of RSV Highs and Lows, with Tina Tan, MD
Gestational Low-Dose Aspirin Does Not Increase Risk of IBD Flares in Women
Riha Bhatt, MD: Mimickers and Concurrent Diseases in Pediatric IBD
© 2024 MJH Life Sciences

All rights reserved.